Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isoindolone compounds and their use as metabotropic glutamate receptor potentiators

Isoindolone compounds and their use as metabotropic glutamate receptor potentiators

US Patent 7968570 · Granted Jun 28, 2011

Estimated economic value: $12,615,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucocorticoid receptor agonists2025
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the trea2024
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2024
3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereo2023
Glucocorticoid receptor agonists2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS2023
Naphthyridinone derivatives and their use in the treatment of arrhythmia2022
Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein int2022
Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein intera2022